A Senate committee’s legislation would deliver for the US dietary supplement industry on compelling guidance on new dietary ingredient notifications but has too much for its liking about mandatory regulatory registration of all supplements.
While some industry trade groups have supported mandatory listing requirements, they joined the opponents in questioning the provision included in the Senate Health, Education, Labor and Pension Committee’s bill filed on 26 May for five-year reauthorizations of the FDA’s user fee programs
In addition to requiring supplement marketers to register their products with the Food and Drug Administration for listing in a public database, the provisions would authorize the agency to prohibit sales of products that are compliant with all manufacturing and labeling regulations